Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Segmentation

2. Preface

3. Executive Summary

4. Impact of COVID-19 on Global Animal Vaccines Market

5. Global Animal Vaccines Market Trends & Insights

6. Global Animal Vaccines Market Dynamics
6.1. Growth Drivers
6.2. Challenges
6.3. Impact Analysis

7. Global Animal Vaccines Market Hotspot & Opportunities

8. Global Animal Vaccines Market Regulations and Policies

9. Global Animal Health Market Overview

10. Animal Vaccine Research & Development Process Map

11. Global Animal Vaccines Market Outlook, 2016-2026F
11.1. Market Size & Analysis
11.1.1. Market Revenue (USD Million)
11.2. Market Share & Analysis
11.2.1. By Type
11.2.1.1. Porcine Vaccines
11.2.1.2. Aquaculture Vaccines
11.2.1.3. Ruminants Vaccines
11.2.1.4. Companion Animals Vaccines
11.2.1.4.1. Canine Vaccines
11.2.1.4.2. Feline Vaccines
11.2.1.5. Poultry Vaccines
11.2.1.6. Livestock Vaccines
11.2.2. By Diseases
11.2.2.1. Porcine Diseases
11.2.2.2. Aquaculture Diseases
11.2.2.3. Ruminants Diseases
11.2.2.4. Companion Animals Diseases
11.2.2.4.1. Canine Diseases
11.2.2.4.2. Feline Diseases
11.2.2.5. Poultry Diseases
11.2.2.6. Livestock Diseases
11.2.3. By Technology
11.2.3.1. Live Attenuated Vaccines
11.2.3.2. Livestock Inactivated Vaccines
11.2.3.3. Toxoid Vaccines
11.2.3.4. Recombinant Vaccines
11.2.3.5. Other (DNA vaccines)
11.2.4. By Region
11.2.4.1. North America
11.2.4.2. South America
11.2.4.3. Europe
11.2.4.4. Asia Pacific
11.2.4.5. Middle East and Africa
11.2.5. By Competitors
11.2.5.1. Competition Characteristics
11.2.5.2. Market Share & Analysis
11.2.5.3. Competitive Matrix

12. North America Animal Vaccines Market Outlook, 2016-2026F
12.1. Market Size & Analysis
12.1.1. Market Revenue (USD Million)
12.2. Market Share & Analysis
12.2.1. By Type
12.2.2. By Diseases
12.2.3. By Technology
12.2.4. By Country
12.2.4.1. The US
12.2.4.2. Canada
12.3. The US Animal Vaccines Market Outlook, 2016-2026F
12.3.1. Market Size & Analysis
12.3.1.1. Market Revenue (USD Million)
12.3.2. Market Share & Analysis
12.3.2.1. By Type
12.4. Canada Animal Vaccines Market Outlook, 2016-2026F
12.4.1. Market Size & Analysis
12.4.1.1. Market Revenue (USD Million)
12.4.2. Market Share & Analysis
12.4.2.1. By Type

13. South America Animal Vaccines Market Outlook, 2016-2026F
13.1. Market Size & Analysis
13.1.1. Market Revenue (USD Million)
13.2. Market Share & Analysis
13.2.1. By Type
13.2.2. By Diseases
13.2.3. By Technology
13.2.4. By Country
13.2.4.1. Brazil
13.2.4.2. Others
13.3. Brazil Animal Vaccines Market Outlook, 2016-2026F
13.3.1. Market Size & Analysis
13.3.1.1. Market Revenue (USD Million)
13.3.2. Market Share & Analysis
13.3.2.1. By Type

14. Europe Animal Vaccines Market Outlook, 2016-2026F
14.1. Market Size & Analysis
14.1.1. Market Revenue (USD Million)
14.2. Market Share & Analysis
14.2.1. By Type
14.2.2. By Diseases
14.2.3. By Technology
14.2.4. By Country
14.2.4.1. Germany
14.2.4.2. The UK
14.2.4.3. France
14.2.4.4. Italy
14.2.4.5. Spain
14.2.4.6. Others
14.3. Germany Animal Vaccines Market Outlook, 2016-2026F
14.3.1. Market Size & Analysis
14.3.1.1. Market Revenue (USD Million)
14.3.2. Market Share & Analysis
14.3.2.1. By Type
14.4. The UK Animal Vaccines Market Outlook, 2016-2026F
14.4.1. Market Size & Analysis
14.4.1.1. Market Revenue (USD Million)
14.4.2. Market Share & Analysis
14.4.2.1. By Type
14.5. France Animal Vaccines Market Outlook, 2016-2026F
14.5.1. Market Size & Analysis
14.5.1.1. Market Revenue (USD Million)
14.5.2. Market Share & Analysis
14.5.2.1. By Type
14.6. Italy Animal Vaccines Market Outlook, 2016-2026F
14.6.1. Market Size & Analysis
14.6.1.1. Market Revenue (USD Million)
14.6.2. Market Share & Analysis
14.6.2.1. By Type
14.7. Spain Animal Vaccines Market Outlook, 2016-2026F
14.7.1. Market Size & Analysis
14.7.1.1. Market Revenue (USD Million)
14.7.2. Market Share & Analysis
14.7.2.1. By Type

15. Asia Pacific Animal Vaccines Market Outlook, 2016-2026F
15.1. Market Size & Analysis
15.1.1. Market Revenue (USD Million)
15.2. Market Share & Analysis
15.2.1. By Type
15.2.2. By Diseases
15.2.3. By Technology
15.2.4. By Country
15.2.4.1. China
15.2.4.2. India
15.2.4.3. Japan
15.2.4.4. Thailand
15.2.4.5. Australia
15.2.4.6. Others
15.3. China Animal Vaccines Market Outlook, 2016-2026F
15.3.1. Market Size & Analysis
15.3.1.1. Market Revenue (USD Million)
15.3.2. Market Share & Analysis
15.3.2.1. By Type
15.4. India Animal Vaccines Market Outlook, 2016-2026F
15.4.1. Market Size & Analysis
15.4.1.1. Market Revenue (USD Million)
15.4.2. Market Share & Analysis
15.4.2.1. By Type
15.5. Japan Animal Vaccines Market Outlook, 2016-2026F
15.5.1. Market Size & Analysis
15.5.1.1. Market Revenue (USD Million)
15.5.2. Market Share & Analysis
15.5.2.1. By Type
15.6. Thailand Animal Vaccines Market Outlook, 2016-2026F
15.6.1. Market Size & Analysis
15.6.1.1. Market Revenue (USD Million)
15.6.2. Market Share & Analysis
15.6.2.1. By Type
15.7. Australia Animal Vaccines Market Outlook, 2016-2026F
15.7.1. Market Size & Analysis
15.7.1.1. Market Revenue (USD Million)
15.7.2. Market Share & Analysis
15.7.2.1. By Type

16. Middle East & Africa Animal Vaccines Market Outlook, 2016-2026F
16.1. Market Size & Analysis
16.1.1. Market Revenue (USD Million)
16.2. Market Share & Analysis
16.2.1. By Type
16.2.2. By Diseases
16.2.3. By Technology
16.2.4. By Country
16.2.4.1. Saudi Arabia
16.2.4.2. UAE
16.2.4.3. South Africa
16.2.4.4. Others
16.3. Saudi Arabia Animal Vaccines Market Outlook, 2016-2026F
16.3.1. Market Size & Analysis
16.3.1.1. Market Revenue (USD Million)
16.3.2. Market Share & Analysis
16.3.2.1. By Type
16.4. South Africa Animal Vaccines Market Outlook, 2016-2026F
16.4.1. Market Size & Analysis
16.4.1.1. Market Revenue (USD Million)
16.4.2. Market Share & Analysis
16.4.2.1. By Type
17. Key Strategic Imperatives for Success and Growth
18. Competition Outlook (Whichever Applicable)
18.1. Competition Matrix
18.1.1. Target Markets
18.1.2. Research & Development
18.1.3. Collaborations & Strategic Alliances
18.1.4. Key Business Expansion Initiatives
18.1.5. Business Restructuring – Mergers, Acquisitions, JVs
18.1.6. Strategic Initiatives
18.2. Company Profiles (Business Description, Product Categories, Market Focused Product Category, Business Segments, Market Focused Business Segment, Financials, Strategic Alliances/ Partnerships, Future Plans)
18.2.1. Elanco
18.2.2. Ceva
18.2.3. Phibro Animal Health Corporation
18.2.4. Neogen Corporation
18.2.5. Intas Pharmaceuticals Ltd.
18.2.6. Biog?nesis Bag?
18.2.7. Ourofino Sa?de Animal
18.2.8. Virbac
18.2.9. Zoetis
18.2.10. Merc & Co., Inc.
18.2.11. Boehringer Ingelheim International GmbH
19. Disclaimer